Development of a sensitive multiplexed open circuit potential system for the detection of prostate cancer biomarkers

Lai Chun Caleb Wong, Pawan Jolly, Pedro Estrela

Research output: Contribution to journalArticle

1 Citation (Scopus)
59 Downloads (Pure)

Abstract

We report the development of a sensitive label-free, cost-effective detection system with simultaneous multi-channel measurement of open circuit potential (OCP) variations for the detection of prostate specific antigen (PSA). We demonstrate a significant increase of 600 times in the sensitivity as compared to the reported literature. To accurately measure OCP variations, a complete monolithic field-effect transistor (FET)-input ultra-low input bias current instrumentation amplifier is used to form the electronic circuit to measure the variation between a working electrode and a reference electrode. This amplifier electronic system setup provides a differential voltage measurement with high input impedance and low input bias current. Since no current is applied to the electrochemical system, a true and accurate measurement of the variation can be performed. This is the first report on the use of DNA aptamers with OCP system where we employed a DNA aptamer against PSA. An optimised ratio of anti-PSA DNA aptamer with 6-mercapto-1-hexanol (MCH) was used to fabricate the aptasensor using gold electrodes. The electrodes are hosted in a cell with an automated flow system. A wide range of concentrations of PSA (0.1 ng/mL to 100 ng/mL) were injected through the system. The sensor could potentially differentiate 0.1 ng/mL PSA from blank measurement, which is well below the required clinical range (>1 ng/mL). The sensor was also challenged with 4% human serum albumin and human kallikrein2 as control proteins where the sensor demonstrated excellent selectivity. The developed system can be further generalised to various other targets using specific probes.
Original languageEnglish
Pages (from-to)701-706
JournalBioNanoScience
Volume8
Issue number2
Early online date1 Apr 2017
DOIs
Publication statusPublished - 1 Jun 2018

Fingerprint

Prostate-Specific Antigen
Antigens
Tumor Biomarkers
Nucleotide Aptamers
Networks (circuits)
Electrodes
DNA
Bias currents
Sensors
Voltage measurement
Field effect transistors
Serum Albumin
Gold
Labels
Proteins
Costs

Keywords

  • Biosensors

Cite this

Development of a sensitive multiplexed open circuit potential system for the detection of prostate cancer biomarkers. / Wong, Lai Chun Caleb; Jolly, Pawan; Estrela, Pedro.

In: BioNanoScience, Vol. 8, No. 2, 01.06.2018, p. 701-706.

Research output: Contribution to journalArticle

@article{5aa66d1d36d6415bba8a66a1f477949a,
title = "Development of a sensitive multiplexed open circuit potential system for the detection of prostate cancer biomarkers",
abstract = "We report the development of a sensitive label-free, cost-effective detection system with simultaneous multi-channel measurement of open circuit potential (OCP) variations for the detection of prostate specific antigen (PSA). We demonstrate a significant increase of 600 times in the sensitivity as compared to the reported literature. To accurately measure OCP variations, a complete monolithic field-effect transistor (FET)-input ultra-low input bias current instrumentation amplifier is used to form the electronic circuit to measure the variation between a working electrode and a reference electrode. This amplifier electronic system setup provides a differential voltage measurement with high input impedance and low input bias current. Since no current is applied to the electrochemical system, a true and accurate measurement of the variation can be performed. This is the first report on the use of DNA aptamers with OCP system where we employed a DNA aptamer against PSA. An optimised ratio of anti-PSA DNA aptamer with 6-mercapto-1-hexanol (MCH) was used to fabricate the aptasensor using gold electrodes. The electrodes are hosted in a cell with an automated flow system. A wide range of concentrations of PSA (0.1 ng/mL to 100 ng/mL) were injected through the system. The sensor could potentially differentiate 0.1 ng/mL PSA from blank measurement, which is well below the required clinical range (>1 ng/mL). The sensor was also challenged with 4{\%} human serum albumin and human kallikrein2 as control proteins where the sensor demonstrated excellent selectivity. The developed system can be further generalised to various other targets using specific probes.",
keywords = "Biosensors",
author = "Wong, {Lai Chun Caleb} and Pawan Jolly and Pedro Estrela",
year = "2018",
month = "6",
day = "1",
doi = "10.1007/s12668-017-0408-0",
language = "English",
volume = "8",
pages = "701--706",
journal = "BioNanoScience",
issn = "2191-1630",
publisher = "Springer Science + Business Media",
number = "2",

}

TY - JOUR

T1 - Development of a sensitive multiplexed open circuit potential system for the detection of prostate cancer biomarkers

AU - Wong, Lai Chun Caleb

AU - Jolly, Pawan

AU - Estrela, Pedro

PY - 2018/6/1

Y1 - 2018/6/1

N2 - We report the development of a sensitive label-free, cost-effective detection system with simultaneous multi-channel measurement of open circuit potential (OCP) variations for the detection of prostate specific antigen (PSA). We demonstrate a significant increase of 600 times in the sensitivity as compared to the reported literature. To accurately measure OCP variations, a complete monolithic field-effect transistor (FET)-input ultra-low input bias current instrumentation amplifier is used to form the electronic circuit to measure the variation between a working electrode and a reference electrode. This amplifier electronic system setup provides a differential voltage measurement with high input impedance and low input bias current. Since no current is applied to the electrochemical system, a true and accurate measurement of the variation can be performed. This is the first report on the use of DNA aptamers with OCP system where we employed a DNA aptamer against PSA. An optimised ratio of anti-PSA DNA aptamer with 6-mercapto-1-hexanol (MCH) was used to fabricate the aptasensor using gold electrodes. The electrodes are hosted in a cell with an automated flow system. A wide range of concentrations of PSA (0.1 ng/mL to 100 ng/mL) were injected through the system. The sensor could potentially differentiate 0.1 ng/mL PSA from blank measurement, which is well below the required clinical range (>1 ng/mL). The sensor was also challenged with 4% human serum albumin and human kallikrein2 as control proteins where the sensor demonstrated excellent selectivity. The developed system can be further generalised to various other targets using specific probes.

AB - We report the development of a sensitive label-free, cost-effective detection system with simultaneous multi-channel measurement of open circuit potential (OCP) variations for the detection of prostate specific antigen (PSA). We demonstrate a significant increase of 600 times in the sensitivity as compared to the reported literature. To accurately measure OCP variations, a complete monolithic field-effect transistor (FET)-input ultra-low input bias current instrumentation amplifier is used to form the electronic circuit to measure the variation between a working electrode and a reference electrode. This amplifier electronic system setup provides a differential voltage measurement with high input impedance and low input bias current. Since no current is applied to the electrochemical system, a true and accurate measurement of the variation can be performed. This is the first report on the use of DNA aptamers with OCP system where we employed a DNA aptamer against PSA. An optimised ratio of anti-PSA DNA aptamer with 6-mercapto-1-hexanol (MCH) was used to fabricate the aptasensor using gold electrodes. The electrodes are hosted in a cell with an automated flow system. A wide range of concentrations of PSA (0.1 ng/mL to 100 ng/mL) were injected through the system. The sensor could potentially differentiate 0.1 ng/mL PSA from blank measurement, which is well below the required clinical range (>1 ng/mL). The sensor was also challenged with 4% human serum albumin and human kallikrein2 as control proteins where the sensor demonstrated excellent selectivity. The developed system can be further generalised to various other targets using specific probes.

KW - Biosensors

U2 - 10.1007/s12668-017-0408-0

DO - 10.1007/s12668-017-0408-0

M3 - Article

VL - 8

SP - 701

EP - 706

JO - BioNanoScience

JF - BioNanoScience

SN - 2191-1630

IS - 2

ER -